ITGA9 rs116692768: What Your Genotype Means

What each genotype means

Understanding the Variant

The variant rs116692768 is a specific change in the DNA sequence located within an intron of the ITGA9 gene on chromosome 3. In genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. Because this variant is located in an intronic region—a part of the gene that does not code for the final protein product—it does not directly alter the amino acid sequence of the ITGA9 protein. Instead, researchers study such variants to see if they might influence how the gene is regulated or expressed. This specific SNP has been identified in large-scale pharmacogenomic studies, which aim to understand how genetic differences between individuals influence their response to medications. It is important to note that while statistical associations have been reported, the functional impact of this specific variant on antidepressant response remains a subject of ongoing scientific investigation.

The Role of ITGA9

The ITGA9 gene provides instructions for making a protein called integrin alpha-9. Integrins are a family of transmembrane receptors that facilitate cell-to-cell and cell-to-matrix adhesion, playing critical roles in how cells communicate with their environment. In the context of the nervous system, ITGA9 has been described as a membrane receptor for neurotrophins, which are proteins that support the growth, survival, and differentiation of neurons. Because the brain's ability to adapt and reorganize—a process known as neuroplasticity—is thought to be a key component of how antidepressants work, researchers have hypothesized that genes involved in neuronal signaling and structural integrity might influence treatment outcomes. While ITGA9 is clearly important for cellular function, its specific contribution to the complex biological pathways involved in depression and the mechanism of action of SSRI medications like citalopram is still being mapped by the scientific community.

Research and Evidence Strength

The evidence linking rs116692768 to antidepressant response is considered moderate and stems from large-scale meta-analyses, such as those combining data from the STAR*D and GENDEP studies. These studies identified a statistically significant association between this variant and symptom improvement in patients treated with citalopram or escitalopram. However, replication of these findings has been partial. For instance, while the association was replicated in the PGRN-AMPS study, it was not consistently observed in other cohorts like NEWMEDS. This variability is common in pharmacogenomics, where the effect of a single genetic variant is often small and can be influenced by other genetic factors, environmental variables, and the clinical characteristics of the study population. Consequently, while the association is scientifically interesting, it is not currently used as a definitive clinical tool to predict how an individual will respond to antidepressant therapy.

Clinical Considerations

It is vital to understand that genetic variants like rs116692768 are not diagnostic tools for depression, nor are they reliable predictors of treatment success on their own. Depression is a complex condition influenced by a wide array of genetic, environmental, and lifestyle factors. Pharmacogenomic research is still in its early stages, and most findings are intended to help scientists understand the biological underpinnings of drug response rather than to guide immediate clinical decisions. If you are currently taking or considering citalopram or escitalopram, do not make any changes to your medication regimen based on genetic information. Always consult with your psychiatrist, primary care physician, or a qualified pharmacist before making decisions about your treatment. They are the only ones who can evaluate your clinical history, current symptoms, and overall health to determine the most appropriate therapeutic approach for you.

Frequently asked questions

Sources & further reading